3 employees
Pelican Therapeutics develops biologic agents that represent the next generation of TNF based immunotherapy.
2009
$15M
from 1 investors over 1 rounds
Pelican Therapeutics, Inc. raised $15M on May 19, 2016
Investors: Cancer Prevention and Research Institute of Texas